Loading clinical trials...
Loading clinical trials...
An Adaptive, Randomized, Double Blind, Placebo Controlled Three Part Study of the Safety, Tolerability, and Pharmacokinetics of MRX-8 Administered Intravenously to Healthy Volunteers in Single Ascending and Multiple Ascending Dose Cohorts
Conditions
Interventions
MRX-8
Placebo
Locations
1
United States
Celerion
Tempe, Arizona, United States
Start Date
November 29, 2020
Primary Completion Date
December 1, 2021
Completion Date
December 1, 2021
Last Updated
August 24, 2023
NCT07256522
NCT04592640
NCT04854278
NCT07253896
NCT06244537
NCT05583006
Lead Sponsor
MicuRx
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions